Skip to content

2021/2022 Integrated Annual Report

Striving to constantly expand access to health care

Servier took part in Access Accelerated

This global partnership enhances access to non-communicable disease (NCDs) prevention, treatment and care in low- and lower-middle-income countries.

A comprehensive range of health care solutions

Brand-name medicines, generic medicines, and digital health


A range of over 1,500 generic medicines

501 million

standard boxes of brand-name medicines were produced in 2021/2022


Continuously innovating to serve patient needs

Our answers:

  • Symphogen our center of excellence for high-quality monoclonal and bispecific antibodies ;
  • Cutting-edge expertise in small molecules, antisense oligonucleotides (ASOs) and monoclonal antibodies ;

  • Open innovation driving collective intelligence: the R&D center in Boston and the R&D Institute in Paris-Saclay.


Collaborations with 29 international patient organizations in 2021/2022


Over 70 scientific partnerships and collaborations around the world with pharmaceutical companies, biotechs, start-ups and academic labs


Furthering the efforts of the pharmaceutical industry in quid profonde mutation

Our answers:

  • Continuously adapting our production facilities and supply chain in order to best respond to patient needs ;
  • Significant presence in emerging economies.

More than 9 out of 10 boxes

of Servier brand-name medicines are sold outside France


of the active ingredients used in the Group’s brand-name medicines are produced by Servier in France


Combating climate change and related risks

Our answers:

  • Biodiversity: In 2021, Servier joined act4nature international, a voluntary commitment to protect biodiversity ;

  • 1 EcoDesign Program to even more effectively integrate social and environmental concerns into the medicine life cycle ;
  • 2023 target 100% of Servier brand-name medicines to be developed in accordance with an ecodesign approach.


Reduction targeted across all our direct and indirect emissions by 2030


Between 2021 and 2022, we reduced the volume of air freight between our production facilities in Loiret (France) and Arklow (Ireland) by 5.2%, switching instead to sea freight


Fostering a fulfilling and meaningful working environment for employees

Our answers:

Our employer promise: Why choose us?

  • Do meaningful and purpose-driven work ;
  • Rise to the challenge with us ;
  • Drive one’s own career.


HR labels obtained in 2022 including 34 subsidiaries certified Great Place to Work, 1 Happy Trainees and 7 Top Employer


overall engagement score among Servier Group employees in 20221

79 %

of employees would recommend Servier as a great place to work1

(1) Annual engagement survey conducted with the Gallup Institute – 2022 Group results

Download the 2021/2022 Integrated Annual Report

Download the 2021/2022 Integrated Annual Report